ROBERTS 063 (Agrylin 0.5 mg)
Generic Name: anagrelide
Pill with imprint ROBERTS 063 is White, Capsule-shape and has been identified as Agrylin 0.5 mg. It is supplied by Shire US Inc.
Agrylin is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Agrylin 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ROBERTS 063
Agrylin
- Generic Name:
- anagrelide
- Imprint:
- ROBERTS 063
- Strength:
- 0.5 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous coagulation modifiers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Shire US Inc
- National Drug Code (NDC):
- 54092-0063
More about Agrylin (anagrelide)
- Agrylin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Generic Availability
- Drug class: miscellaneous coagulation modifiers
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
